These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 32060059)
21. Characteristics of Alpha-1 Antitrypsin-Deficient Individuals in the Long-term Oxygen Treatment Trial and Comparison with Other Subjects with Chronic Obstructive Pulmonary Disease. Stoller JK; Aboussouan LS; Kanner RE; Wilson LA; Diaz P; Wise R; Ann Am Thorac Soc; 2015 Dec; 12(12):1796-804. PubMed ID: 26653189 [TBL] [Abstract][Full Text] [Related]
26. Alpha 1 Antitrypsin-Deficient Macrophages Have Impaired Efferocytosis of Apoptotic Neutrophils. Lee J; Lu Y; Oshins R; West J; Moneypenny CG; Han K; Brantly ML Front Immunol; 2020; 11():574410. PubMed ID: 33329539 [TBL] [Abstract][Full Text] [Related]
27. Tumor necrosis factor-α driven inflammation in alpha-1 antitrypsin deficiency: a new model of pathogenesis and treatment. Hurley K; Reeves EP; Carroll TP; McElvaney NG Expert Rev Respir Med; 2016 Feb; 10(2):207-22. PubMed ID: 26634397 [TBL] [Abstract][Full Text] [Related]
28. Protease-Specific Biomarkers to Analyse Protease Inhibitors for Emphysema Associated with Alpha 1-Antitrypsin Deficiency. An Overview of Current Approaches. Viglio S; Bak EG; Schouten IGM; Iadarola P; Stolk J Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494436 [TBL] [Abstract][Full Text] [Related]
33. Monocytes and Macrophages in Alpha-1 Antitrypsin Deficiency. Belchamber KBR; Walker EM; Stockley RA; Sapey E Int J Chron Obstruct Pulmon Dis; 2020; 15():3183-3192. PubMed ID: 33311976 [TBL] [Abstract][Full Text] [Related]
34. Impact of a Health Management Program on Healthcare Outcomes among Patients on Augmentation Therapy for Alpha 1-Antitrypsin Deficiency: An Insurance Claims Analysis. Campos MA; Runken MC; Davis AM; Johnson MP; Stone GA; Buikema AR Adv Ther; 2018 Apr; 35(4):467-481. PubMed ID: 29616482 [TBL] [Abstract][Full Text] [Related]
35. Testing for alpha-1 antitrypsin in COPD in outpatient respiratory clinics in Spain: A multilevel, cross-sectional analysis of the EPOCONSUL study. Calle Rubio M; Soriano JB; López-Campos JL; Soler-Cataluña JJ; Alcázar Navarrete B; Rodríguez González-Moro JM; Miravitlles M; Barrecheguren M; Fuentes Ferrer ME; Rodriguez Hermosa JL; PLoS One; 2018; 13(6):e0198777. PubMed ID: 29953442 [TBL] [Abstract][Full Text] [Related]
36. Lung Inflammation in alpha-1-antitrypsin deficient individuals with normal lung function. Kokturk N; Khodayari N; Lascano J; Riley EL; Brantly ML Respir Res; 2023 Feb; 24(1):40. PubMed ID: 36732772 [TBL] [Abstract][Full Text] [Related]
37. Bronchoscopic Lung Volume Reduction in Patients with Emphysema due to Alpha-1 Antitrypsin Deficiency. Everaerts S; Hartman JE; Van Dijk M; Koster TD; Slebos DJ; Klooster K Respiration; 2023; 102(2):134-142. PubMed ID: 36549279 [TBL] [Abstract][Full Text] [Related]
38. The Role of Neutrophils in Alpha-1 Antitrypsin Deficiency. McCarthy C; Reeves EP; McElvaney NG Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S297-304. PubMed ID: 27564664 [TBL] [Abstract][Full Text] [Related]
39. α1 Antitrypsin deficiency: current best practice in testing and augmentation therapy. Campos MA; Lascano J Ther Adv Respir Dis; 2014 Oct; 8(5):150-61. PubMed ID: 25013223 [TBL] [Abstract][Full Text] [Related]
40. ICS Use May Modify FEV1 Decline in α1-Antitrypsin Deficiency Patients with Relatively High Blood Eosinophils. Low EV; Hughes SM; Zaffarullah S; Kantas D; Stockley RA; Turner AM Respiration; 2018; 95(2):114-121. PubMed ID: 29253843 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]